Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-25-000020

Chief Legal Officer gave up 5,049 shares (to pay taxes)

  • Chief Legal Officer acquired 56,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Siegel Jolie · Chief Legal Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-13 Shares withheld for taxes : show line 1 in the form −2,135 $3.20 $6,832 54,353 D
2025-02-14 Grant or award : show line 2 in the form +56,500 110,853 D
2025-02-14 Shares withheld for taxes : show line 3 in the form −2,914 $3.18 $9,267 107,939 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-02-14 Grant or award : show line 4 in the form Stock Option (Right to Buy) +84,700 84,700 D
Loading xslF345X05/wk-form4_1739915720.xml…